Thu, February 15, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Steve Sakwa Maintained (VNO) at Sell with Decreased Target to $26 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Andy Chen Initiated (VRTX) at Buy on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Shyam Patil Maintained (ZG) at Hold with Increased Target to $60 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Shyam Patil Maintained (Z) at Hold with Increased Target to $60 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Dan Levy Maintained (BWA) at Buy with Decreased Target to $40 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
John Sourbeer Maintained (BRKR) at Strong Buy with Increased Target to $94 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Bryan Burgmeier Maintained (WM) at Strong Buy with Increased Target to $226 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Stephanie Yee Maintained (WM) at Hold with Increased Target to $197 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Devin Dodge Maintained (WM) at Buy with Increased Target to $178 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Steve Barger Maintained (WAB) at Buy with Increased Target to $155 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Allison Poliniak Maintained (WAB) at Buy with Increased Target to $150 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Bascome Majors Maintained (WAB) at Buy with Increased Target to $160 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Justin Long Maintained (WAB) at Buy with Increased Target to $155 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Oliver Holmes Downgraded (WAB) to Hold and Held Target at $135 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
John Mazzoni Maintained (WCN) at Buy with Increased Target to $185 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Devin Dodge Maintained (WCN) at Buy with Increased Target to $178 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Walter Spracklin Maintained (WCN) at Buy with Increased Target to $182 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Christopher Mcgratty Maintained (WCN) at Buy with Increased Target to $175 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Joshua Long Reiterated (WEN) at Buy and Held Target at $22 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Jon Tower Maintained (BLMN) at Hold with Increased Target to $29 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Silvan Tuerkcan Maintained (BNTC) at Buy with Increased Target to $10 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Stephen Bersey Downgraded (AKAM) to Sell and Decreased Target to $96 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Scott Heleniak Maintained (AIG) at Buy with Increased Target to $80 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Michael Zaremski Maintained (AIG) at Buy with Decreased Target to $81 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Joshua Spector Maintained (ALB) at Hold with Decreased Target to $125 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Jerry Revich Maintained (ALSN) at Strong Sell with Increased Target to $55 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Joseph Stringer Reiterated (ALNY) at Strong Buy and Held Target at $200 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $165 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Andy Chen Initiated (ALNY) at Hold on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Brad Heffern Maintained (ADC) at Buy with Decreased Target to $63 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Rachel Vatnsdal Maintained (ADPT) at Buy with Decreased Target to $8 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Kunal Madhukar Maintained (ANGI) at Hold with Increased Target to $3 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Brad Erickson Maintained (ANGI) at Hold with Increased Target to $3.25 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Steve Byrne Upgraded (APD) to Strong Buy and Held Target at $264 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Robert Mason Maintained (atmu) at Buy with Increased Target to $29 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
James Ratcliffe Maintained (ATUS) at Hold with Decreased Target to $3 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Steven Cahall Maintained (ATUS) at Hold with Decreased Target to $2 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
John Hodulik Maintained (ATUS) at Strong Buy with Decreased Target to $4 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Daniel Brennan Maintained (AVTR) at Strong Buy with Increased Target to $29 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Patrick Donnelly Maintained (AVTR) at Strong Buy with Increased Target to $30 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Conor McNamara Maintained (AVTR) at Buy with Increased Target to $29 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Catherine Schulte Maintained (AVTR) at Buy with Increased Target to $26 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Jeffrey Zekauskas Maintained (AVTR) at Buy with Increased Target to $29 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Luke Sergott Maintained (AVTR) at Buy with Increased Target to $27 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
George Tong Maintained (BFAM) at Strong Buy with Increased Target to $108 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Jeffrey Meuler Maintained (BFAM) at Hold with Increased Target to $105 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Jeffrey Silber Maintained (BFAM) at Hold with Increased Target to $92 on, Feb 15th, 2024
[ Thu, Feb 15th 2024 ]: WOPRAI
Patrick Moley Maintained (BGC) at Buy with Increased Target to $8.5 on, Feb 15th, 2024

Rachel Vatnsdal Maintained (ADPT) at Buy with Decreased Target to $8 on, Feb 15th, 2024

Rachel Vatnsdal of JP Morgan, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $11 to $8 on, Feb 15th, 2024.

Rachel has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Rachel's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $10 on, Tuesday, October 24th, 2023


This is the rating of the analyst that currently disagrees with Rachel

  • David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $6 on, Monday, November 13th, 2023